Masayo Shamoto‐Nagai
Masayo Shamoto‐Nagai publishes mostly in Molecular Biology, Neurology and Cellular and Molecular Neuroscience, on topics such as Parkinson's Disease Mechanisms and Treatments, Mitochondrial Function and Pathology and Alzheimer's disease research and treatments.
- World rank
- #467,891 of 7,710,434 ranked researchers
- Rank in Japan
- #4,705 of 383,136
- Works
- 41
- Citations
- 2.7k
- Citations per work
- 65.2
What does Masayo Shamoto‐Nagai research?
Masayo Shamoto‐Nagai's work is mostly in Medicine (34%), Biochemistry, Genetics and Molecular Biology (28%), Neuroscience (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1741.1%
- Health Sciences1433.7%
- Medicine1433.7%
- Everything else1025.2%
- 1Molecular Biology28% of their works
- 2Neurology18% of their works
- 3Cellular and Molecular Neuroscience13% of their works
- 4Physiology8% of their works
- 5Complementary and alternative medicine4% of their works
- 6Pharmacology3% of their works
Research topics
- Parkinson's Disease Mechanisms and Treatments
- Mitochondrial Function and Pathology
- Alzheimer's disease research and treatments
- Nuclear Receptors and Signaling
- Neurotransmitter Receptor Influence on Behavior
- Nerve injury and regeneration
- Cholinesterase and Neurodegenerative Diseases
- Ubiquitin and proteasome pathways
Which keywords describe Masayo Shamoto‐Nagai's research?
The keywords of their largest research topics: Oxidative Stress, Neurodegeneration, Mitochondrial Dysfunction, Dopaminergic Neurons, Parkinson's Disease, a-Synuclein, Genetic Risk Factors and Neurodegenerative Diseases.
- Ubiquitin
- Serotonin
- Dopamine
- BDNF
- Nurr1
- Tau Pathology
- Reactive Oxygen Species
- Neurodegenerative Diseases
- Genetic Risk Factors
- Dopaminergic Neurons
- Neurodegeneration
- Oxidative Stress
- Mitochondrial Dysfunction
- Parkinson's Disease
- a-Synuclein
- Mitochondria
- Amyloid Hypothesis
- NR4A2
- Acetylcholinesterase
- Cholinesterase Inhibitors
- Neurotrophins
- Proteasome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Oxidative Stress313 topics
- Neurodegeneration293 topics
- Mitochondrial Dysfunction252 topics
- Dopaminergic Neurons232 topics
- Parkinson's Disease232 topics
- Genetic Risk Factors181 topic
- a-Synuclein181 topic
- Neurodegenerative Diseases112 topics
- Mitochondria71 topic
- Reactive Oxygen Species71 topic
- Amyloid Hypothesis61 topic
- Tau Pathology61 topic
- NR4A251 topic
- Nurr151 topic
- Acetylcholinesterase41 topic
- BDNF41 topic
- Cholinesterase Inhibitors41 topic
- Dopamine41 topic
- Neurotrophins41 topic
- Serotonin41 topic
- Proteasome31 topic
- Ubiquitin31 topic
Where does Masayo Shamoto‐Nagai work?
Masayo Shamoto‐Nagai's main affiliation in the publication record is Aichi Gakuin University, Japan.
How many publications and citations does Masayo Shamoto‐Nagai have?
OpenAlex counts 41 works and 2,675 citations for Masayo Shamoto‐Nagai, an h-index of 26, ranking #467,891 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Masayo Shamoto‐Nagai. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.